Polyradiculoneuropathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-06-05
EMA Authorised: HyQvia (human normal immunoglobulin) — Baxalta Innovations GmbH
The EMA has authorised HyQvia (human normal immunoglobulin) from Baxalta Innovations GmbH for use in immunologic deficiency syndromes and re…